China Aiming To Slash Hospital Medical Cost Growth By Half
This article was originally published in PharmAsia News
Transitionally strong urban hospital market will be cut even deeper, forcing drug makers to actively expand to lower-tiered county hospitals and grassroots clinics for growth.
You may also be interested in...
If you missed some of the many significant events in China’s policy and regulatory landscape in 2016, here is your opportunity to catch up on month-by-month developments.
Two new sets of data on growth in China’s turbulent pharma sector paint a mixed and complex picture, indicating both challenges and opportunities ahead for multinational and domestic firms in the country.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.